Richard Curtis
Psychiatry · Richmond, VANPI 1972593598
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 348 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 17.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,425 and has fallen 98.9% since, to $16 in 2024. Among psychiatry clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 348 payments — averaging $14.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$927
- Lundbeck LLC$731
- Otsuka America Pharmaceutical, Inc.$534
- Takeda Pharmaceuticals U.S.A., Inc.$448
- Johnson & Johnson$352
- Neurocrine Biosciences, Inc.$296
- plus $2K from 23 others
What the payments were for
- Food & beverage$5,15299%
- Education$431%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 85 | $927 |
| Lundbeck LLC | 43 | $731 |
| Otsuka America Pharmaceutical, Inc. | 30 | $534 |
| Takeda Pharmaceuticals U.S.A., Inc. | 34 | $448 |
| Johnson & Johnson | 20 | $352 |
| Neurocrine Biosciences, Inc. | 18 | $296 |
| Tris Pharma Inc | 17 | $246 |
| Vanda Pharmaceuticals Inc. | 15 | $235 |
| Ironshore Pharmaceuticals Inc. | 14 | $226 |
| Eisai Inc. | 9 | $159 |
| Alkermes, Inc. | 7 | $152 |
| Neos Therapeutics, LP | 7 | $100 |
| Teva Pharmaceuticals USA, Inc. | 7 | $97 |
| Corium, LLC | 4 | $94 |
| Supernus Pharmaceuticals, Inc. | 5 | $92 |
| Shire North American Group Inc | 6 | $87 |
| Noven Therapeutics, LLC | 5 | $65 |
| Vertical Pharmaceuticals, LLC | 4 | $64 |
| Bausch Health US, LLC | 3 | $58 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $45 |
| Almatica Pharma LLC | 2 | $36 |
| Alfasigma USA, Inc. | 2 | $35 |
| Adlon Therapeutics L.p. | 2 | $24 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Jazz Pharmaceuticals Inc. | 1 | $15 |
| Neuronetics, Inc. | 1 | $15 |
| Merck | 1 | $15 |
| Avanir Pharmaceuticals, Inc. | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$5,195 in reported general payments places this provider in the 90th percentile of 884 psychiatry providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 13 | $358 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 13 | $241 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Richmond
- Susan KornsteinRichmond$74K
- Ashvin PatelRichmond$68K
- James SellmanRichmond$18K
- Frederick MoellerRichmond$16K
- Robert SewardRichmond$14K
- William KernodleRichmond$14K
- John LeeRichmond$10K
- Tamar CarmelRichmond$8K
- Niku SinghFalls Church$2.5M
- David ScheidererRoanoke$2.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.